Item
SODIUM ASCORBATE STD USP/FCC LUWEI (3920031 215 04M)
Food Ingredient
Attributes
- Gluten-free
- Halal
- Kosher
- PHO-free
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Shuangfeng Industrial Park Zichuan District Zibo City, SD 255000 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Allergens.pdf | 1/15/2025 | 1/15/2027 |
| Animal Testing Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Animal Testing Statement.pdf | 1/15/2025 | 1/15/2027 |
| Lot Code | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | batch number statement.pdf | 1/21/2025 | 1/21/2028 |
| BSE - TSE | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | BSETSE ERTIFICATE-VC-NA.pdf | 9/18/2021 | 9/17/2024 |
| GMO | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | C5997442025.pdf | 3/24/2025 | 12/22/2025 |
| CoA Sample | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | COA-240243015.pdf | 1/21/2025 | 1/21/2027 |
| Country of Origin | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Country of Origin.pdf | 1/20/2025 | 1/20/2028 |
| Dietary Supplement Questionnaire | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Dietary Supplement Questionnaire.pdf | 1/20/2025 | 1/20/2026 |
| EtO Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | ETO DECLARATION- Na.pdf | 1/21/2025 | 1/21/2027 |
| HACCP Process Flow Diagram | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Flow Chart_Sodium Ascorbate.pdf | 10/23/2024 | 10/23/2026 |
| FSVP Assessment Form | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | FSVP Assessment Form.pdf | 2/4/2025 | 2/4/2026 |
| Gluten | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Gluten Free Statement.pdf | 1/21/2025 | 1/21/2027 |
| GRAS/NDI/ODI Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | GRAS CERTIFICATE.pdf | 1/21/2025 | 1/21/2028 |
| HARPC Food Safety Plan (Item) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | HACCP PLAN FOR SODIUM ASCORBATE 2.pdf | 1/21/2025 | 1/21/2028 |
| HACCP | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | HACCP PLAN FOR SODIUM ASCORBATE 2.pdf | 1/21/2025 | 1/21/2028 |
| Heavy Metal | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | heavy metal-Na.pdf | 5/10/2024 | 5/10/2026 |
| Label Sample | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | IMG_20250112_100857.jpg | 1/21/2025 | 1/21/2026 |
| No Animal Ingredient Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Ingredient Statement 1.pdf | 1/21/2025 | 1/21/2026 |
| Ingredient Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Ingredient Statement.pdf | 10/25/2022 | 10/25/2023 |
| Irradiation Status Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | irradition.pdf | 1/21/2025 | 1/21/2027 |
| Item Questionnaire | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Item Questionnaire.pdf | 1/21/2025 | 1/21/2028 |
| National Bioengineered Food Disclosure Standard (Simplified) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | National Bioengineered Food Disclosure Standard Simplified.pdf | 1/21/2025 | 1/21/2028 |
| Natural | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | NaturalSynthetic Statement Template.pdf | 1/21/2025 | 1/21/2026 |
| Organic | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | NotApplicable_Organic.pdf | 2/4/2025 | 2/4/2027 |
| Nutrition | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Nutrition.pdf | 1/21/2025 | 1/21/2028 |
| Kosher | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | OUV2-F021800.pdf | 3/31/2024 | 3/31/2025 |
| Food Contact Packaging Certificate of Compliance | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Package Statement.pdf | 1/21/2025 | 1/21/2027 |
| Phthalate Esters Letter | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Phthalate Esters.pdf | 1/21/2025 | 1/21/2026 |
| Label Guidance | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | PM-7027-04.pdf | 12/8/2021 | 12/8/2023 |
| California Prop. 65 | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | PRO65.pdf | 9/27/2023 | 9/26/2025 |
| Safety Data Sheet (SDS) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | SDS for Na.pdf | 1/21/2025 | 1/21/2028 |
| Sewage Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Sewage Statement.pdf | 1/21/2025 | 1/21/2027 |
| Shelf Life | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Shelf Life Statement for Sodium Ascorbate.pdf | 1/23/2025 | 1/23/2028 |
| Product Specification Sheet | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | SPECIFICATION VCNA.pdf | 1/21/2025 | 1/21/2028 |
| Suitability Requirements | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Suitability Requirements.pdf | 1/23/2025 | 1/23/2028 |
| Pesticide | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | vc.pdf | 6/19/2024 | 6/19/2026 |
| Residual Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | vc.pdf | 5/18/2024 | 5/18/2025 |
| Label Claims | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | VC-NA ORIGIN CARTON.jpg | 9/18/2021 | 9/18/2023 |
| Vegan/Vegetarian Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | VEGAN CERTIFICATE.pdf | 3/29/2023 | 3/28/2025 |
| WADA/NSF/NFL Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | WADA statement-Na.pdf | 1/23/2025 | 1/23/2027 |
| Halal | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | 印尼HALAL主页面证书2026.11.29.pdf | 11/30/2022 | 11/29/2026 |
